BiondVax Pharmaceuticals Ltd ADR
North American company
News & analysis
Times are shown in GMT-4, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
BiondVax Pharmaceuticals Ltd is engaged in the healthcare sector. Its main activity is the commercialization and manufacturing of flu vaccine. Its product is designed to provide multi-season and multi-strain protection against some human influenza virus strains, including both seasonal and pandemic flu strains. The company recently concluded two Phase I/II trials in which the multimeric-001 universal flu vaccine was shown to be safe and immunogenic.BiondVax Pharmaceuticals Ltd is a clinical stage biopharmaceutical company. The company is engaged in developing, manufacturing and commercializing immunomodulation therapies for infectious diseases.
Latest BVXV News